Tau protein forms insoluble filamentous inclusions that are closely associated with nerve cell death in many neurodegenerative diseases. How neurons die in these tauopathies is unclear. We report that living neurons with tau inclusions from P301S-tau mice expose abnormally high amounts of phosphatidylserine because of the production of reactive oxygen species (ROS). Consequently, co-cultured phagocytes (BV2 cells or primary microglia) identify and phagocytose the living neurons, thereby engulfing insoluble tau inclusions. To facilitate engulfment, neurons induce contacting microglia to secrete the opsonin milk-fat-globule EGF-factor-8 (MFGE8) and nitric oxide (NO), whereas neurons with tau inclusions are rescued when MFGE8 or NO production is prevented. MFGE8 expression is elevated in transgenic P301S-tau mouse brains with tau inclusions and in tau inclusion-rich brain regions of several human tauopathies, indicating shared mechanisms of disease. Preventing phagocytosis of living neurons will preserve them for treatments that inhibit tau aggregation and toxicity.
In Brief Brelstaff et al. report that live neurons containing aggregated tau externalize phosphatidylserine, activate microglia, and are phagocytosed. Preventing key steps in this pathway rescues living neurons. A similar phagocytic signal is found in human tauopathies. The authors propose that inhibiting phagocytosis may spare neurons with tau aggregates.
INTRODUCTION
The assembly of tau protein into abnormal inclusions underlies many human neurodegenerative diseases , but how neurons die in tauopathies is still unknown. Transgenic mice that express neuron-specific human mutant 0N4R P301S-tau reproduce much of the tau pathology observed in a family with frontotemporal dementia due to a P301S-tau mutation (Bugiani et al., 1999) , with neurons in the central and peripheral nervous systems developing filamentous tau inclusions and progressive neurodegeneration between 3 and 5 months of age Mellone et al., 2013) . Peripheral neurons are also affected in human tauopathies (Kawasaki et al., 1987; Nishimura et al., 1993) , making them a relevant model of disease. We reported that the pentameric oligothiophene dye pFTAA specifically detects filamentous tau aggregates in dorsal root ganglion (DRG) neurons from P301S-tau mice (Brelstaff et al., 2015a (Brelstaff et al., , 2015b , enabling investigation of how tau aggregates may lead to cell death. Observing pFTAA + cultured DRG neurons showed that they are slowly removed, without showing signs of apoptosis or necroptosis (Brelstaff et al., 2015a) . Such slow kinetics accord with phagocytic cell death of live neurons by microglia (Neher et al., 2011) . Glial cells, particularly microglia, are thought to be crucial in neurodegeneration (Salter and Stevens, 2017; Spangenberg and Green, 2017) . Microglial activation has been associated with tau aggregation in frontotemporal dementia (FTDP-17T) (Bellucci et al., 2011) and P301S-tau mouse brains (Bellucci et al., 2004) and has also been implicated in tau spreading through phagocytosis (Boló s et al., 2016; Maphis et al., 2015) .
Death of cells through phagocytosis occurs extensively (Brown et al., 2015) and is required for programmed cell death in C. elegans (Johnsen and Horvitz, 2016) . Most studies of neuronal cell death through microglial phagocytosis have relied on the induction of phagocytic activity by inflammatory signals (Brown and Neher, 2014) . Inflammatory microglia instigate living neurons to expose the ''eat me'' signal phosphatidylserine (PS) and perform phagocytosis through release of opsonins (e.g., MFGE8). MFGE8 simultaneously binds target-exposed PS (Hanayama et al., 2002) and phagocytic avb3 vitronectin receptors, causing cytoskeletal rearrangements that facilitate target engulfment. Whether non-apoptotic exposure of PS occurs on diseased neurons and whether it activates microglial inflammation and phagocytosis are unknown.
We have investigated how tau inclusion-bearing neurons die, showing that live neurons with aggregated tau produce sufficient reactive oxygen species (ROS) to externalize PS and activate microglial phagocytosis. Preventing key steps in this pathway leads to the rescue of living neurons.
that also expressed P301S-tau (detected with anti-human tau HT7; Figures 1A and 1B; p < 0.0001). PS exposure was highest in cultures containing P301S-tau + neurons from 5-month-old mice, while significantly lower AnnV labeling was present in DRG neurons cultured from 5-month-old C57BL/6 (C57) control mice, tau + or tau À neurons from 2-month-old P301S mice, which express hyperphosphorylated forms of P301S-tau but do not contain filamentous tau aggregates (Delobel et al., 2008; Mellone et al., 2013) , and tau + or tau À neurons from 5-month-old Alz17 mice that express wild-type 2N4R human tau but do not develop tau aggregates (Brelstaff et al., 2015a; Probst et al., 2000) (Figure 1C ; p < 0.001 5-month-old P301S-tau HT7 + versus all others).
pFTAA/AnnV + neurons were viable, as assessed by these criteria: (1) impermeability to nuclear dyes (PI, Figure 1D ; DAPI, Figure S1A ), in contrast to strong staining of fixed/permeable cells; (2) retention of calcein-AM, similar to pFTAA À neurons, in contrast to fixed/permeable cells showing no calcein-AM labeling ( Figure 1D ); and (3) no active caspase-3, which drives PS exposure on apoptotic cells (Nagata et al., 2016) (Figure 1E ), in contrast to caspase-3-dependent exposure of PS on all neurons exposed to pro-apoptotic staurosporine (Sts; 250 nM) (Figure 1E) . Also, only Sts-induced PS exposure, but not that induced by P301S-tau, was inhibited by the pan-caspase inhibitor Boc-Asp(O-methyl)-FMK (BAF) ( Figure S1B ). Staining with pFTAA was not the cause of PS exposure, as enhanced AnnV staining intensity was present prior to pFTAA application (Figure S1C) . Thus, pFTAA + neurons with exposed PS are alive.
To investigate what drives PS exposure, we measured ROS production, as ROS can activate PS transporters (Sarkar et al., 2015; Schreiber et al., 2018) , and oxidized PS is a powerful pro-phagocytic signal (Tyurin et al., 2014) . DRG neurons with P301S-tau aggregates displayed significantly higher dihydroethidium (DHE) fluorescence compared with pFTAA À neurons in the same cultures (Figures 2A and 2B ; p < 0.0001), indicating higher ROS production. Moreover, PS exposure was ROS dependent, as preincubation with the antioxidants N-acetyl-Lcysteine (NAC) or TEMPOL for 48 hr reduced AnnV binding values compared to untreated pFTAA + neurons ( Figure 2C ; p < 0.0001, untreated pFTAA + neurons vs all). In contrast, the pro-oxidant arsenite induced rapid PS exposure in the absence of cell permeabilization or death in all neurons ( Figure 2C ). Thus, ROS production associated with tau aggregates is a component of the signaling pathway that leads to PS externalization in P301S-tau neurons but is insufficient to cause cell death, unlike ROS-driven ferroptosis/oxytosis (Tan et al., 2001; Yang and Stockwell, 2016 (NO) and MFGE8 production, MFGE8 having been shown to be a key opsonin via PS binding in the nervous system (Boddaert et al., 2007; Kranich et al., 2010; Neher et al., 2011) . DRG neurons from 5-month-old P301S mice induced a significant increase in the expression and secretion of MFGE8 ( Figures 3A-3C ) specifically in cultures containing neurons with P301S-tau aggregates, as no increase in its expression was detected when BV2 cells were co-cultured with DRG neurons from 5-month-old Alz17 or C57 mice or 2-month-old P301S mice. Importantly, DRG neurons cultured from 5-month-old P301S mice also induced the release of MFGE8 from co-cultured primary microglia (containing 90% microglia and 10% astrocytes) from C57 mice, MFGE8 concentration being $6-fold higher than that measured from equivalent numbers of BV2 cells ( Figure 3E ). No MFGE8 was detected in medium conditioned by microglia alone or microglia from negative-control MFGE8 knockout (KO) mice (Silvestre et al., 2005) .
NO was also significantly elevated ($3-fold) in medium conditioned by neurons from 5-month-old P301S mice co-cultured with BV2 cells (Figure 3D ), but no increase was detected in cocultures of BV2 cells with neurons from 5-month-old Alz17 or C57 mice or 2-month-old P301S mice. More NO was also released when neurons from 5-month-old P301S mice were co-cultured with primary microglia from C57 mice, but there was no increase in its release from MFGE8 KO microglia (Figure 3F) , suggesting a mutual mechanism of induction between NO-and MFGE8-initiated signaling pathways. Notably, no increase in MFGE8 in BV2 cell lysates or in released MFGE8 or NO was detected when BV2 cells were co-cultured in transwell inserts regardless of neuronal origins ( Figures 3A-3D ), indicating a requirement for close contact between neurons and microglia to achieve activation of NO and MFGE8 production.
To assess the intensity and the specificity of stimulation by pFTAA + neurons, BV2 cells were treated with 100 ng/mL lipopolysaccharide (LPS) for 24 hr and washed prior to their addition to the various neuronal cultures ( Figure S2 ). LPS induced similarly elevated amounts of MFGE8 and NO regardless of neuron source or placement of BV2 cells in contact or transwell inserts. Thus, cultures of neurons with tau inclusions that expose PS provide a microglial stimulus that is as robust as that of LPS, assessed by MFGE8 and NO production. (E and F) Elevated MFGE8 (E) or NO (F) in medium conditioned by primary microglia from C57 mice co-cultured in contact with DRG neurons from 5-month-old P301S mice; microglia from MFGE8 KO mice are negative controls. Mean ± SD, n = 3 independent microglial preparations, one-way ANOVA, **p < 0.01 (MFGE8), *p < 0.05 (NO).
(G) Increased MFGE8 immunostaining intensity in frontal motor cortex of 5-month-old P301S mice compared with 5-month-old C57 mice; MFGE8 KO mouse is negative control; 25 mm section at interaural 5.12 mm, bregma 1.32 mm; brown, DAB; blue, cresyl violet. Scale bar, 130 mm. Inset, 65 mm.
(H and I) Elevated MFGE8 (H) in 5-month-old P301S-tau brains. Lysates from cortex (Ctx), brain stem (BS), and cerebellum (Cb) of 5-month-old C57, 5-month-old P301S-tau, and 5-month-old Alz17 mice probed with anti-MFGE8; MFGE8 KO brain lysate is negative control. rec, recombinant mouse MFGE8. (I) Densitometry of MFGE8 expression normalized to b-actin. Significantly higher MFGE8 expression in P301S versus C57BL/6 Ctx (**p < 0.01), BS (****p < 0.0001), Cb (**p < 0.01), and P301S versus ALz17 BS (****p < 0.0001). Mean ± SD, n = 3 independent preparations, two-way ANOVA, Bonferroni corrected. (J) Elevated MFGE8 expression in brain extracts from cortex (Ctx) of FTDP-17T patients with two different MAPT mutations (P301L, +3) or sporadic Pick's disease but not in extracts from patients with C9orf72 hexanucleotide expansions and TDP-43 aggregates. No expression is found in the cerebellum, where tau pathology is absent in all cases. Human milk MFGE8 is a positive control.
To demonstrate the relevance of the results from the culture systems to the in vivo conditions, brain sections from C57 and P301S mice were stained for the presence of MFGE8 and protein extracts from cortex, brain stem, and cerebellum were analyzed for MFGE8 expression. Less MFGE8 immunoreactivity was evident in the cortex of C57 mice compared with that of P301S mice, though some immunostaining was present in the C57 brains compared with MFGE8 KO controls (Figure 3G) . Similarly, extracts from the brains of 5-month-old P301S mice contained significantly higher amounts of MFGE8 compared with lysates from age-matched C57 or Alz17 mice band intensities being slightly higher than background staining in MFGE8 KO lysates ( Figures 3H and 3I) . Expression of MFGE8 was especially prominent in the brain stem, in which a high number of neurons with tau aggregates is found .
MFGE8 Expression Is Elevated in the Frontal Cortex of Human Tauopathies
To determine whether a similar pattern of activation occurs in human tauopathies, we compared the expression of MFGE8 in brain extracts from the frontal cortex of healthy human controls and three cases each of inherited tauopathies (P301L and +3 mutations in MAPT; Hutton et al., 1998; Mirra et al., 1999; Spillantini et al., 1997) and three cases of sporadic Pick's disease (case details in STAR Methods). Increased MFGE8 expression was found in the cortical extracts of all human tauopathy cases compared with healthy controls ( Figure 3J ). MFGE8 was barely detected in the cerebellum of P301L-tau cases, an area with little or no tau pathology. We also examined brain extracts from C9orf72 cases containing TDP-43 pathology in the cortex but little tau, as detected by antibody AT8. No increase in MFGE8 was found in the cortex or cerebellum of C9orf72 cases, consistent with the specific expression of MFGE8 in tauopathies and strengthening the relevance of our findings in P301S mice for human disease.
Phagocytes Engulf Neurons with Tau Inclusions that Expose PS
We next investigated if phagocytes specifically engulf P301S-tau + neurons with tau inclusions. Figure 4A shows that when neurons were cultured in contact with BV2 cells, more than 50% of the HT7 + neurons were lost after 4 days (p < 0.001). There was no loss of HT7 + neurons when BV2 cells were co-cultured in a transwell, showing that physical contact was necessary for neuronal loss. In contrast, no HT7 + neuron loss was found when BV2 cells were co-cultured with neurons from 5-monthold Alz17 mice or 2-month-old P301S mice. The extent of phagocytosis that followed BV2 activation by neurons was similar to that produced by LPS, in agreement with the similar amounts of MFGE8 and NO produced by both stimuli ( Figure S2E ; p < 0.05). Importantly, microglia from the cortex of neonatal C57 mice caused a similar extent of neuronal loss as BV2 cells ( Figure 4B ; p < 0.05), whereas no neuronal loss occurred with microglia from MFGE8 KO mice ( Figure 4B ). Macrophages prepared from bone marrow (BMDMs) of C57 mice also caused neuron loss, while macrophages from MFGE8 KO mice did not ( Figure S2F ; p < 0.01).
We noted several examples of IB4 + phagocytes in close proximity to cultured pFTAA + neurons and some internalization of pFTAA + aggregates ( Figure 4C ). To examine whether endogenous phagocytes were responsible for the loss of tau aggregate-containing neurons that occurs over 2-3 weeks, we eliminated the phagocytes by treatment (4 hr) with leucine methyl ester (LME) (Jebelli et al., 2015) , followed by an overnight incubation to ensure death of phagocytes. We found that $90% of the pFTAA + neurons were maintained after phagocytes were eliminated from the cultures, whereas only $70% of the neurons remained in untreated cultures after 14 days ( Figure 4D ; p < 0.0001). Because it was reported recently that living necroptotic cells also externalize PS (Zargarian et al., 2017) , we tested whether the neurons were dying by necroptosis. In contrast to the abolition of neuron loss caused by LME, neuron loss was not prevented by the RIPK1 inhibitor necrostatin-1 (Degterev et al., 2008) , indicating that neuron loss was not due to necroptosis ( Figure S4 ). Thus, four types of phagocytes (BV2 cells, primary microglia, BMDMs, and resident phagocytes) are activated by pFTAA + neurons that then phagocytose them, thereby causing neuronal loss.
Insoluble Tau Inclusions Are Transferred into Microglia after Phagocytosis
To further demonstrate phagocytosis of pFTAA + neurons with tau inclusions by microglia, we pre-labeled BV2 cells with IB4-Alexa Fluor 594 before adding them to pFTAA pre-labeled neurons from 5-month-old P301S or C57 mice. Both cell types were washed extensively before co-culture to remove free dyes. After 4 days, BV2 cells were collected and sorted by fluorescence-activated cell sorting (FACS). Figure 4E shows that a minor but significant proportion of BV2 cells was double-labeled with pFTAA and IB4-594 in the population exposed to P301S-tau-derived DRG neurons (4.9%, gated fraction P6), but none was present in the P6-gated population exposed to C57-derived DRG neurons, indicating that the BV2 cells had engulfed prelabeled tau inclusions. To confirm that the pFTAA + material inside BV2 cells was insoluble tau, sorted cells were lysed in 5% SDS and filtered through a cellulose acetate membrane trap (Figure 4F) . Tau from the P6-gated pFTAA/IB4 + population was retained on the filter, as detected by HT7, but no tau was retained from the C57 P6-gated population or the P4-gated singlelabeled BV2 population. Sarkosyl-insoluble tau extracted from 5-month-old P301S mouse brain served as the positive control . These data indicate that pFTAA + tau aggregates are transferred to BV2 cells during their co-culture with pFTAA + DRG neurons, confirming that phagocytosis had occurred. Many instances of pFTAA + P301S-tau were also detected in microglia in brains from 5-month-old P301S mice. Figure 4G shows an example of a double-labeled pFTAA/HT7 + neuron with an intact nucleus inside an Iba1-stained microglial cell in the facial nucleus (FN). Engulfment of the whole neuron is evident in the confocal image ( Figure 4G ). Similar examples were present in the cortex from P301S mice ( Figure S4 ).
Brains from 5-month-old P301S mice showed significant alterations in microglial morphology in the FN and other areas of the brain stem rich in tau aggregates, with marked increases in microglial proximity to neurons ( Figure 4H ), as previously noted (Bellucci et al., 2004) . Interestingly, the neurons against which microglia were closest showed an altered morphology, although their nuclei retained a normal appearance. To establish that the proximity of tau aggregate-bearing neurons to microglia was induced by the presence of P301S-tau, we mapped the relative spatial distribution of neurons and microglia ( Figures 4I and 4J) .
A clustered pattern of microglia intermingled with neurons was evident in brains of P301S mice compared with C57 or MFGE8 KO mice ( Figure 4I ). Quantification showed that there was a 2-fold increase in the interaction strength between microglia and neurons in P301S mice compared with C57 controls ( Figure 4J ). However, microglia were also closely associated with the neurons (Figure 4I , quantified in Figure 4J ) in (J) Quantification of proximity; significant increases in interaction strength between P301S-tau + neurons and microglia in P301S-tau and P301S-tau/MFGE8 KO mice compared with C57 or MFGE8 KO controls. *p < 0.05, **p < 0.01, and ***p < 0.001, one-way ANOVA, Bonferroni corrected.
5-month-old double homozygous MFGE8 KO/P301S mice with tau aggregates. Thus, the change in location of microglia depended more on the state of neurons containing P301S-tau aggregates than on MFGE8 per se that instead seems necessary for phagocytosis.
Inhibiting Phagocytosis Rescues Living Neurons
To show further evidence that neurons with tau inclusions are eaten alive in an MFGE8-dependent manner, we co-cultured neurons from 5-month-old P301S mice with BV2 cells and added either excess AnnV to mask neuronal PS (Krahling et al., 1999; Neher et al., 2011) or the cyclo peptide cRGDfV (cRGD), to mask MFGE8 RGD binding to the av vitronectin receptor subunit (Asano et al., 2004) . AnnV significantly reduced the loss of tau + (HT7 + ) neurons from the cultures (p < 0.01), while the cRGD peptide showed a trend toward protection ( Figures 5A and 5D ). Interestingly, both treatments reduced MFGE8 and NO secretion in the cocultures (Figures 5B, p < 0.01 and 5C, p < 0.001). Reduced phagocytosis was not due to a priori inactivation of BV2 microglia by AnnV or the cRGD peptide, as neither compound reduced MFGE8 expression or MFGE8 and NO release when added to LPS-activated cultures of BV2 cells ( Figures S5A-S5C ). Hence, phagocytosis induced by the DRG neurons with tau inclusions requires MFGE8 and NO production in BV2 cells, which, when abrogated, leads to the rescue of living neurons.
Because AnnV and cRGD treatments inhibited both MFGE8 and NO production, we investigated whether direct inhibition of NO production using inducible NO synthase (iNOS) inhibitors would also abrogate phagocytosis. The results show that N-(3-(aminomethyl)benzyl)acetamidine (1400W) or aminoguanidine (AG) significantly reduced the production of NO from BV2 cells induced by neurons from 5-month-old P301S mice ( Figure 4I ; 1400W, p < 0.05; AG, p < 0.001) and that both compounds inhibited the loss of tau + neurons ( Figure 4G ; 1400W, p < 0.05; AG, p < 0.01). Moreover, the iNOS inhibitors also abrogated the production of MFGE8 ( Figure 4H ; p < 0.001), further demonstrating the reciprocity between NO signaling and MFGE8 production. Thus, NO induced in phagocytes by neurons with tau inclusions is an essential component of the phagocytic process.
DISCUSSION
The presence of tau filaments is correlated with neurodegeneration in familial and sporadic tauopathies, but the mechanisms by which assembled tau may cause neuronal cell death remain elusive . This study implicates neurons with intracellular filamentous tau aggregates in instigating a type of cell death whereby living neurons under stress expose the ''eat me'' signal PS and activate phagocytic cells that recognize, engulf, and dispose them while still alive. Our study adds neurons with tau inclusions to a growing list of cells that are phagocytosed while still alive as a homeostatic mechanism to regulate cell numbers and remove potentially unfit cells (Merino et al., 2015) . It has been suggested that neuronal cell death in neurodegenerative diseases is the consequence of a breakdown of cooperative processes between neurons and other cells, not least microglia (De Strooper and Karran, 2016) . Microglia are the resident immune cells of the brain that sometimes interact beneficially with surrounding cells and sometimes have deleterious effects, especially during inflammation (Aguzzi et al., 2013; Boche et al., 2013) . By instigating the exposure of PS, intracellular P301S-tau aggregates cause microglia to release opsonins, which facilitate engulfment, and NO that can perpetuate an inflammatory state. In contrast to its exposure in apoptosis, here PS could be re-internalized, emphasizing the fact that the neurons are alive, and it is phagocytosis that kills them.
Interest is increasing in inflammation as contributing to neurodegeneration (Boló s et al., 2017) . A role for innate immune factors has long been acknowledged in Alzheimer's disease (AD) (Eikelenboom and Stam, 1982) and some tauopathies (Singhrao et al., 1996) , but how neuroinflammation is instigated in diseases with intracellular protein aggregates in unclear. Here, neurons with filamentous tau aggregates led to microglial activation through close contact, establishing a causal relationship between intracellular aggregation and an inflammatory response. The signaling pathway starts in the neurons by tau aggregatemediated ROS production, causing neuronal PS exposure, followed by NO production in the phagocytes that regulates release of MFGE8 necessary for phagocytosis (see Figure 5 for summary scheme). We further extend the model in which NO is postulated to promote release of MFGE8 (Hornik et al., 2016) by proposing that MFGE8 released as a result of iNOS/NO stimulation feeds back onto the avb3 receptor to amplify iNOS/NO output. Indeed, avb3 has been implicated in the activation of astrocytes, which also produce MFGE8 in the brain (Lagos-Cabré et al., 2017) . It is interesting that lack of MFGE8 did not prevent the proximity of microglia to neurons in the facila nucleus of 5-month-old double crossed MFGE8 KO/P301S-tau +/+ mice. However, many other pairs of signals are expressed on target cells and phagocytes that might facilitate proximity, even though MFGE8 is still required for phagocytosis (Neher et al., 2013; Rothlin et al., 2015) . Which of these signals predominate under each disease condition remains to be explored.
Phagocytosis of alive tau inclusion-bearing neurons may have implications for potential therapies. We found increased expression of MFGE8 in the frontal cortex of FTD cases with MAPT mutations (P301L and FTDP+3) or sporadic Pick's disease but not in the cerebellum of P301L cases, showing that the expression level of MFGE8 depends on the presence of tau aggregates. Preservation of neurons, albeit with tau inclusions, preserves a working network and provides a substrate for potential therapies, which by altering aggregation and toxicity may well be able to prevent neuronal loss.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: Cultures DRG neurons were cultured in DMEM-based growth medium lacking anti-oxidants as described previously (Brelstaff et al., 2015a) . Primary microglia were prepared from cortices of newborn C57 mice or MFGE8 KO mice and expanded in medium containing 40% DMEM with 10% heat inactivated FBS and 60% L929 cell conditioned medium (Sawada et al., 1990) . BMDM cells were prepared from bone marrows of long limbs of 3-4 week-old mice (Trouplin et al., 2013) . BV2 cells were expanded from an original stock obtained from ATCC. For co-culture, 200,000 BV2 cells or primary microglia or BMDM per culture (a ratio of about 20:1) were added either directly to the medium or physically separated using a 0.4 mm pore transwell insert (Costar). Co-cultures were maintained in DMEM, 1% PSF, 5% heat inactivated FBS, and 2 mM GlutaMax (GIBCO) for 4 days before analysis.
METHOD DETAILS
Live cell labeling For live labeling with AnnV, neurons were cultured for 7 days, washed, and labeled with 3 mM pFTAA and 0.1 mg/ml PI or DAPI (Brelstaff et al., 2015a) . Medium was exchanged for HBSS containing 2.5 mM CaCl 2 and 0.5% (v/v) Alexa Fluorâ-647-conjugated AnnV for 15 min at RT in the dark, then returned to growth medium and imaged on a Leica DMI 4000B microscope using a Leica DFC3000 G camera and the Leica application suite 4.0.0.11706.
LME treatment
Following 4 h of incubation with LME (50 mM) in normal growth medium, LME was removed by 3 washes with PBS and cultures were returned into growth medium overnight to ensure the death of the endogenous phagocytes. The next day, cultures were stained with pFTAA, returned to growth medium and counted. The same fields of neurons were imaged over 14 days.
Anti-oxidant and arsenite treatments NAC or TEMPOL (5 mM final concentration) were added in growth medium for 2 days after which cells were washed and labeled with AnnV-647. Arsenite (0.5 mM) was added for 15 min before washing and labeling with AnnV-647.
Immunocytochemistry
Dissociated DRG neurons were fixed either in 100% ethanol or 4% PFA for 20 min and permeabilised in PBS containing 0.3% triton x-100 (PBST). Antibodies were applied in PBST as described previously (Brelstaff et al., 2015a) . Fluorescent images were captured on a Leica DMI 4000B microscope as described above. Images were analyzed using ImageJ (Rasband, W.S., ImageJ, U.S. National Institutes of Health, Bethesda, Maryland, USA, http://imagej.nih.gov/ij/,1997-2014). Confocal images were taken on a Leica SP8 TCS microscope using LAS X version 2.0.1.14392 software.
Immunohistochemistry
Fresh mouse brains were immediately fixed in 4% PFA for 24-48 h and sunk in PBS containing 30% sucrose. Coronal sections (25 mm) were cut on a freezing microtome (Bright Instruments). Floating sections were permeablised in PBST and stained in PBST with primary antibodies at 4 C, followed by the appropriate biotin-conjugated secondary antibodies. Staining was revealed using the VECTASTAIN Elite ABC HRP Kit followed by the DAB kit (Vectorlabs). Sections were counter stained in Cresyl Violet and mounted in DPX. (C) The amount of MFGE8 secreted from BV2 cells pretreated with 100 ng/ml LPS for 24 h and cocultured with neurons results in no differences, as described in A.
(D) Treatment of BV2 microglia with LPS as described in (A) induced similar amounts of NO (around 15 µM nitrite equivalents) to those induced by neurons from 5m P301S-tau mice.
(E) The percentage of HT7+ve neurons vs. total βIIItubulin+ve neurons remaining after neurons were cultured with LPS-pre-treated BV2 microglia in contact or via transwells for 4 days. DRG neurons from 5m P301S-tau mice are lost from cultures in contact with LPS pre-treated BV2 microglia (*=p<0.05) but not when BV2 microglia are in transwells. No HT7+ve neurons are lost when BV2 microglia are cultured with neurons from 2m P301S-tau mice or 5m Alz17 mice. Mean ± SD, n=3 independent experiments. 2-way ANOVA, Bonferroni corrected.
(F) Bone marrow-derived macrophages (BMDM) cultured from C57 mice in contact with DRG neurons from 5m P301S-tau mice induced significant loss of htau+ve neurons (p<0.01), but there was no significant loss of neurons when BMDMs were prepared from MFGE8 knockout mice, 1-way ANOVA, Bonferroni corrected. Ratio MFGE8/actin pFTAA, Iba1, nuclei Figure S4 . Loss of P301S-tau neurons is not due to necroptosis. Related to Figure 4 . The rate of pFTAA+ve neuron loss is not altered when DRG cultures from 5m P301S-tau are maintained in the presence of 10 µM necrostatin-1 (Nec1) or 10 µM of the inactive analogue (Nec1i). DRG neurons from 5m P301S-tau mice were maintained in culture for 8 days before addition of the inhibitors. Each day, the number of pFTAA +ve neurons remaining in the same fields was counted. Each point shows mean ± SD, n=3 independent experiments. (A-C) AnnV or cRGD do not inhibit MFGE8 expression (D), MFGE8 secretion (E) or NO production (F) by BV2 cells stimulated with LPS, nor inhibit the intracellular amounts of MFGE8 expressed when BV2 cells are cultured with neurons from 5m P301S-tau mice. Both drugs do inhibit MFGE8 and NO secretion in the co-cultures. * indicates either another isoform of MFGE8 or a breakdown product. Mean ± SD, n=3 independent experiments analysed by 1-way ANOVA, Bonferroni corrected.
